Neural exosome therapy for severe stroke recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a new medicine made from tiny particles (neural exosomes) that may help the brain recover after a severe stroke. It is for people who had a large blood clot removed but still have significant disability shortly after the stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 85 years old.
- You had a severe stroke caused by a blockage in a large vessel in the front part of your brain.
- You had a procedure to remove the clot (thrombectomy), but you still have moderate to severe symptoms after that procedure.
- You were independent before the stroke, meaning you could manage your daily activities without help.
- You are able to have an MRI scan.
- You weigh less than 220 lbs (100 kg).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment using exosomes (tiny particles from stem cells) given through a vein to people who recently had an ischemic stroke. It aims to see if this treatment is safe and helps improve recovery.
This trial is testing a new treatment using stem cells from donated umbilical cord tissue to help people recover from a recent moderate to severe stroke. It is for patients who cannot receive standard clot-busting treatments.
This trial tests an experimental drug given by IV to help people recover arm and leg movement after a severe stroke. It may help improve recovery in the early weeks after a stroke.
This trial tests a new drug, J147, for people who recently had a stroke caused by a blocked artery and have already had a procedure to reopen that artery. It aims to see if the drug can improve recovery.
This trial tests whether Cerebrolysin (a medication given through an IV) can help improve recovery after a stroke when given after a successful clot-removal procedure that happened several hours after the stroke began. It is being tested in people who had a large-vessel stroke in the front of the brain and meets certain imaging criteria. The goal is to see if the drug can reduce disability and improve recovery.
This trial tests an experimental treatment made from stem cells (exosomes) given within a week of a stroke, to see if it can help the brain recover. It is designed for people with moderate stroke symptoms who were otherwise healthy before the stroke.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.